Factors related to delay in the diagnosis of basal cell carcinoma

Journal of Cutaneous Medicine and Surgery

Volumn 17, Issue 1, 2013, Pages 27-32

  Husein ElAhmed, Husein ^a   Gutierrez Salmeron, Maria Teresa ^a   Naranjo Sintes, Ramon ^a   Aneiros Cachaza, Jose ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER DIAGNOSIS; CLINICAL FEATURE; COMORBIDITY; DELAYED DIAGNOSIS; FAMILY HISTORY; FEMALE; HELP SEEKING BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; NON MELANOMA SKIN CANCER; PATIENT DECISION MAKING; PRIORITY JOURNAL; SKIN DEFECT; SKIN EXAMINATION; SKIN ULCER; TELANGIECTASIA; TUMOR LOCALIZATION;

AGED; CARCINOMA, BASAL CELL; DELAYED DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 84875431571     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.2310/7750.2012.12030     Document Type: Article

References (34)

1. Miller SJ. Biology of basal cell carcinoma. J Am Acad Dermatol 1991;24:1-13, doi:10.1016/0190-9622(91)70001-I.
2. Veronese F, Farinelli P, Zavattaro E, et al. Basal cell carcinoma of the head region: therapeutical results of 350 lesions treated with Mohs micrographic surgery. J Eur Acad Dermatol Venereol 2011 Jun 25. DOI: 10.1111/j.1468 3083.2011.04165.x.
3. Silverman MK, Kopf AW, Bart RS, et al. Recurrence rates of basal cell carcinomas. J Dermatol Surg Oncol 1992;18:471.
4. Park AJ, Strick M, Watson JD. Basal cell carcinomas: do they need to be followed up? J R Coll Surg Edinb 1994;39:109.
5. Henrikus D, Girgis A, Redman S, Sanson-Fisher RW. A community study of delay in presenting with signs of melanoma to medical practitioners. Arch Dermatol 1991;127:356-61, doi: 10.1001/archderm.1991.01680030076010.
6. Hollows P, McAndrew PG, Perini MG. Delays in the referral and treatment of oral squamous cell carcinoma. Br Dent J 2000;188: 262-5.
7. Burgess CC, Ramirez AJ, Richards MA, Love SB. Who and what influences delayed presentation in breast cancer? Br J Cancer 1998; 77:1343-8, doi:10.1038/bjc.1998.224.
8. Blum A, Brand CU, Ellwanger U, et al. Awareness and early detection of cutaneous melanoma: an analysis of factors related to delay in treatment. Br J Dermatol 1999;141:783-7, doi:10.1046/j.1365-2133.1999.03196.x.
9. Doherty VR, MacKie RM. Reasons for poor prognosis in British patients with cutaneous malignant melanoma. Br Med J (Clin Res Ed) 1986;292:987-9, doi:10.1136/bmj.292.6526.987.
10. Krige JE, Isaacs S, Hudson DA, et al. Delay in the diagnosis of cutaneous malignant melanoma: a prospective study in 250 patients. Cancer 1991;68:2064-8, doi:10.1002/1097-0142(19911101)68:9, 2064::AID-CNCR2820680937.3.0.CO;2-3.
11. Temoshok L, DiClemente RJ, Sweet DM, et al. Factors related to patient delay in seeking medical attention for cutaneous malignant melanoma. Cancer 1984;54:3048-53, doi:10.1002/1097-0142 (19841215)54:12,3048::AID-CNCR2820541239. 3.0.CO;2-M.
12. Rampen FH, Rumke P, Hart AA. Patients' and doctors' delay in the diagnosis and treatment of cutaneous melanoma. Eur J Surg Oncol 1989;15:143-8.
13. Holden R, Damato BE. Preventable delays in the treatment of intraocular melanoma. Eye 1996;10:127-9, doi:10.1038/eye.1996. 22.
14. Chakravorty SG, Chakravorty SS, Patel RR, et al. Delay in specialist consultation in cancer patients. Indian J Cancer 1993;30:61-6.
15. Richard MA, Grob JJ, Avril MF, et al. Delays in diagnosis and melanoma prognosis (I): the role of patients. Int J Cancer 2000;89: 271-9, doi:10.1002/1097-0215(20000520)89:3,271::AID-IJC10. 3.0.CO;2-7.
16. Cassileth BR, Temoshok L, Frederick BE, et al. Patient and physician delay in melanoma diagnosis. J Am Acad Dermatol 1988; 18:591-8, doi:10.1016/S0190-9622(88)70081-X.
17. Oliviera SA, Christos PJ, Halpern AC, et al. Patient knowledge, awareness, and delay in seeking medical attention for malignant melanoma. J Clin Epidemiol 1999;52:1111-6, doi:10.1016/S0895-4356(99)00083-9.
18. Love N. Why patients delay seeking care for cancer symptoms. What you can do about it. Postgrad Med 1991;89:151-2.
19. Michielutte R, Dignan MB, Sharp PC, et al. Skin cancer prevention and early detection practices in a sample of rural women. Prev Med 1996;25:673-83, doi:10.1006/pmed.1996.0106.
20. Temoshok L, DiClemente RJ, Sweet DM, et al. Prognostic and psychological factors related to delay behavior in patients with cutaneous malignant melanoma. Prog Clin Biol 1984;156:169-79.
21. Blackford S, Roberts D, Salek MS, Finlay A. Basal cell carcinomas cause little handicap. Qual Life Res 1996;5:191-4, doi:10.1007/BF00434740.
22. Wool MS. Understanding denial in cancer patients. Adv Psychosom Med 1988;18:37-53.
23. Moyer A, Levine EG. Clarification of the conceptualization and measurement of denial in psychosocial oncology research. Ann Behav Med 1998;20:149-60, doi:10.1007/BF02884955.
24. Silfen R, Amir A, Regev D, Hauben DJ. Role of physicians and patients in the diagnostic delay of cutaneous malignant melanoma. Ann Plast Surg 2002;49:439-42, doi:10.1097/00000637-200210000-00019.
25. Kassier JP. Patients, physicians and the internet. Health Aff 2000; 19:115-23, doi:10.1377/hlthaff.19.6.115.
26. Blackford S, Roberts D, Salek MS, et al. Basal cell carcinomas cause little handicap. Qual Life Res 1996;5:191-4, doi:10.1007/BF00434740.
27. Antoszewski B, Kasielska A, Fijałkowska M, et al. Face skin neoplasms-reasons for delayed treatment. Pol Przegl Chir 2011; 83:361-6, doi:10.2478/v10035-011-0057-x.
28. Alam M, Goldberg LH, Silapunt S, et al. Delayed treatment and continued growth of nonmelanoma skin cancer. J Am Acad Dermatol 2011;64:839-48, doi:10.1016/j.jaad.2010.06.028.
29. Renzi C, Mastroeni S, Mannooranparampil TJ, et al. Delay in diagnosis and treatment of squamous cell carcinoma of the skin. Acta Derm Venereol 2010;90:595-601, doi:10.2340/00015555-0966.
30. Bath-Hextall FJ, Perkins W, Bong J, Williams HC. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev 2007;(1):CD003412.
31. Kirkup ME, de Berker DA. Clinical measurement of dimensions of basal cell carcinoma: effect of waiting for elective surgery. Br J Dermatol 1999;141:876-9, doi:10.1046/j.1365-2133.1999.03111.x.
32. Gordon PM, Cox NH, Paterson WD, et al. Basal cell carcinoma: are early appointments justifiable? Br J Dermatol 2000;142:446-8, doi:10.1046/j.1365-2133. 2000.03354.x.
33. Dunkley MP, Morris AM. Cutaneous malignant melanoma: audit of the diagnostic process. Ann R Coll Surg Engl 1991;73:248-52.
34. Doherty VR, MacKie RM. Reasons for poor prognosis in British patients with cutaneous malignant melanoma. Br Med J 1986;292: 987-9, doi:10.1136/bmj.292.6526.987.